Creator: Dr. M. Sree Mohana Preetha
Keywords: Chlorpromazine (AHPL) (10mg), Chlorpromazine brands in India, Chlorpromazine, Chlorpromazine (AHPL) (10mg) price, AHPL

Chlorpromazine (AHPL) (10mg) (Chlorpromazine) Drug Price and Information

Information Checked by - Dr. M. Sree Mohana Preetha, Pharm D

Further Checked by - Dr. M. Janani Priya, Pharm D

Last Updated on August 08, 2019

Chlorpromazine (Chlorpromazine (AHPL) (10mg)) is an antipsychotic, tranquilizer and antiemetic drug, prescribed for mental or mood disorders (schizophrenia). It is also used to prevent and treat nausea and vomiting, fearness before surgery, used as an adjunct in the treatment of tetanus.

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.

Chlorpromazine (AHPL) (10mg) - AHPL

Chlorpromazine (AHPL) (10mg) Tablet

Generic : Chlorpromazine

₹ 4.05

10mg

Price Updated on August 08, 2019

Update the Drug Info ADD Drug Info

Substitute/Alternative Medication to Chlorpromazine (AHPL) (10mg)

More ....

When is Chlorpromazine (AHPL) (10mg) prescribed?

It is prescribed for -

⇨ Porphyria

⇨ Hiccups

⇨ Anorexia Nervosa

⇨ Depression

⇨ Schizophrenia

⇨ Walking Corpse Syndrome

⇨ Anosognosia

Disclaimer :

Medindia updates the prices regularly, however, there may be slight discrepancies in the prices displayed. This can be due to the following reasons:

Difference in GST/local taxes
Change in price by the company
Updation of price information may not have happened at the right time

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does not intend to replace professional medical opinion in any manner whatsoever. Please also be aware that Medindia does not buy or sell medication.

Published on Jan 31, 2017
Last Updated on August 08, 2019